Registration of APIs CMC information required for an IND
IND and NDA support Drug master files (DMF) filing
Synonyms/Alias | Boc-Gln-Ala-Arg-Mca;Boc-Gln-Ala-Arg-7-Amino-4-Methylcoumarin;Boc-Gln-Ala-Arg-AMC;113866-20-9;Boc-Gln-Ala-Arg-7-amido-4-methylcoumarin;tert-butyl N-[(2S)-5-amino-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(4-methyl-2-oxochromen-7-yl)amino]-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]carbamate;Boc-Gln-Ala-Arg-AMCA;SCHEMBL2143298;CHEBI:84832;Boc-Gln-Ala-Arg-methylcoumarin amide;Boc-Gln-Ala-Arg-4-methylcoumaryl-7-amide;Boc-Gln-Ala-Arg-4-methyl-coumaryl-7-amide;Q27158101;N(2)-(tert-butoxycarbonyl)-L-glutaminyl-L-alanyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-L-argininamide;N2-[(1,1-Dimethylethoxy)carbonyl]-L-glutaminyl-L-alanyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-L-argininamide;tert-butyl (S)-5-amino-1-((S)-1-((S)-5-guanidino-1-(4-methyl-2-oxo-2H-chromen-7-ylamino)-1-oxopentan-2-ylamino)-1-oxopropan-2-ylamino)-1,5-dioxopentan-2-ylcarbamate; |
M.F/Formula | C29H42N8O8 |
M.W/Mr. | 630.7 |
Sequence | One Letter Code:QAR Three Letter Code:Boc-Gln-Ala-Arg-AMC |
InChI | InChI=1S/C29H42N8O8/c1-15-13-23(39)44-21-14-17(8-9-18(15)21)35-26(42)19(7-6-12-33-27(31)32)36-24(40)16(2)34-25(41)20(10-11-22(30)38)37-28(43)45-29(3,4)5/h8-9,13-14,16,19-20H,6-7,10-12H2,1-5H3,(H2,30,38)(H,34,41)(H,35,42)(H,36,40)(H,37,43)(H4,31,32,33)/t16-,19-,20-/m0/s1 |
InChI Key | LQSLBVXESNRILG-VDGAXYAQSA-N |
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us. We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.